PubMed

Digital pathology imaging artificial intelligence in cancer research and clinical trials: An NCI workshop report.

PMID: 41476571 · 2025-11-14

H, a, l, a, , R, , M, a, k, h, l, o, u, f, ;, , M, i, g, u, e, l, , R, , O, s, s, a, n, d, o, n, ;, , K, e, y, v, a, n, , F, a, r, a, h, a, n, i, ;, , I, r, i, n, a, , L, u, b, e, n, s, k, y, ;, , L, y, n, d, s, a, y, , N, , H, a, r, r, i, s

ЖурналJournal of pathology informatics

Год2025-11-14

PMID41476571

Аннотация

Digital pathology imaging (DPI) is a rapidly advancing field with increasing relevance to cancer diagnosis, research, and clinical trials through large-scale image analysis and artificial intelligence (AI) integration. Despite these advances, regulatory adoption in digital pathology (DP) has lagged; to date, only three AI/ML Software as a Medical Device tool have received FDA clearance, highlighting a validation dataset gap rather than an absence of regulatory pathways. On March 6-7, 2024, the N

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.